Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/1999
11/16/1999CA2078118C Cc-1065 analogs
11/16/1999CA2056402C Therapeutic agent
11/16/1999CA1340824C Neurokinin a antagonists
11/11/1999WO1999057135A1 Antipicornaviral compounds, their preparation and use
11/11/1999CA2326763A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and methods for their synthesis
11/10/1999EP0955310A1 New derivatives of (3,4,7,8,9,10)-hexahydro-6,10-dioxo-6H-pyridazino /1,2-a/ /1,2/ diazepine-1-carboxylic acid, process for their preparation and use for preparation of pharmaceutical agents
11/10/1999EP0955309A1 Inhibitors and substrates of thrombin
11/10/1999EP0954585A2 Human telomerase catalytic subunit
11/10/1999EP0954526A2 Serine protease inhibitors
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0719280B1 Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process
11/10/1999EP0635026B1 Novel lipophilic oligopeptides with immunomodulating activity
11/10/1999EP0610487B1 New aminoacid derivates, process for producing the same and pharmaceutical compositions containing these compounds
11/10/1999CN1234804A Process for preparing pharmacologically acceptable salts of N-(1-(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acids
11/10/1999CN1234229A Apparatus for treatment of immunomediated inflammatory disorders
11/10/1999CN1046269C HIV protease inhibitors
11/09/1999US5981546 Integrin antagonists
11/09/1999US5981511 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
11/09/1999US5981492 Substituted 5-membered ring heterocycles, their preparation and their use
11/09/1999US5981491 Peptides; metalloenzymes; tumor necrosis factor
11/09/1999US5981490 Peptidyl compounds
11/09/1999US5981477 Peptide-metal chelate conjugates
11/09/1999US5980913 A tetrapeptides as vaccine adjuvant
11/04/1999WO1999055832A2 Nucleic acid encoding rate agouti related protein
11/04/1999WO1999055726A1 Certain thiol inhibitors of endothelin-converting enzyme
11/04/1999WO1999055725A1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors
11/04/1999WO1999055724A1 NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS
11/04/1999WO1999055723A1 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
11/04/1999WO1999055669A1 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino)-2-oxopyrrolidin-1-yl]propionate
11/04/1999WO1999055355A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
11/04/1999CA2329929A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
11/04/1999CA2327363A1 Process for the preparation of methyl(2s)-2-¬(3r)-3-(n-¬tert-butyloxycarbonyl|-amino)-2-oxopyrrolidin-1-yl|propionate
11/04/1999CA2324251A1 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
11/04/1999CA2323691A1 Certain thiol inhibitors of endothelin-converting enzyme
11/03/1999EP0953646A2 Herbicide tolerant transgenic plants where the herbicide inhibits prophyrin biosynthesis
11/03/1999EP0853484A4 Novel mu opioid receptor ligands: agonists and antagonists
11/03/1999EP0763055B1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
11/03/1999EP0655069B1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
11/03/1999CN1234039A 3-mercaptoacetylamino-1,5-subsd. 2-oxo-azepon derivatives useful as inhibitor of metrix metalloproteinase
11/03/1999CN1234038A C-end modified (N-subsd.)-2-indyldipeptide used for ICE/ced-3 family cysteine protein enzyme inhibitor
11/02/1999US5977380 Process for preparing N-[1- (S)-ethoxycarbonyl-3- phenylpropyl]-L-alanine derivatives
11/02/1999US5977302 Liquid phase process for the preparation of GnRH peptides
11/02/1999US5977296 Chiral peptide nucleic acid monomers and oligomers
11/02/1999US5977178 Compounds with growth hormone releasing properties
11/02/1999US5977137 Sulfonamide inhibitors of aspartyl protease
11/02/1999US5977075 N-aroylamino acid amides as endothelin inhibitors
11/02/1999US5976858 (s)-(e)-3-(4-morpholine-carbonylleucyl)amino-5-phenyl-1-phenyl sulfonyl-1-pentene and others; antiarthritis/antitumor/ antiinflammatory/antimetastasis agents; treatment of muscular dystrophy, malaria, alzheimer's and autoimmune diseases
11/02/1999US5976851 Methods and compositions for the identification, characterization, and inhibition of farnesyl protein transferase
11/02/1999US5976529 Methods of enzyme therapy by orally administering crosslinked enzyme crystals
11/02/1999US5976495 Peptide derived radionuclide chelators
10/1999
10/30/1999CA2775100A1 Method for giving resistance to weed control compounds to plants
10/28/1999WO1999054346A1 Glutathione derivatives and dosage forms thereof
10/28/1999WO1999054317A1 Cysteine protease inhibitors
10/28/1999WO1999024460B1 Dipeptide nitriles
10/28/1999CA2329712A1 Cysteine protease inhibitors
10/28/1999CA2328731A1 Glutathione derivatives and dosage forms thereof
10/27/1999EP0952151A2 Intermediates for use in preparing novel pyridonecarboxylic acid derivatives or their salts
10/27/1999EP0951471A1 Cycloalkyl inhibitors of protein farnesyltransferase
10/27/1999EP0951470A1 Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
10/27/1999EP0951466A2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/27/1999CN1233288A GnRH-leukotoxin chimeras
10/27/1999CN1233256A Dipeptide benzamidine as a kininogenase inhibitor
10/27/1999CN1233237A Heteroaryl succinamides and their use as metalloproteinase inhibitors
10/26/1999US5973111 Novel compounds that are capable of binding to the active site of interleukin-1b-converting enzyme (ice) and inhibiting activity of that enzyme; administering to treat inflammatory, autoimmune, and neurodegenerative diseases
10/26/1999US5973009 Antioxidant and cytoprotecting activity
10/26/1999US5972989 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/26/1999US5972897 Acylated enol derivatives as prodrugs of elastase inhibitors
10/26/1999US5972894 Peptides having potassium channel opener activity
10/26/1999US5972308 Reacting technetium-99 with a cyclic oligopeptide having amino acid units containing a mercaptan group attached to the ring through a homocysteine unit.
10/26/1999CA2183320C Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
10/21/1999WO1999053021A1 Cell differentiation/proliferation and maintenance factor and uses thereof
10/21/1999WO1999052937A1 Aspartyl dipeptide ester derivatives and sweeteners
10/21/1999WO1999052936A2 Arginine peptide analogs useful as fibroblast growth factor antagonists
10/21/1999WO1999052935A1 Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide
10/21/1999WO1999052933A1 Process for the preparation of resin-bound cyclic peptides
10/21/1999WO1999052929A1 Nucleic acid sequences and proteins associated with aging
10/21/1999WO1999052896A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999WO1999052540A1 Methods for treatment and prevention of infections
10/21/1999WO1999038501A9 Method of regulating glucose metabolism, and reagents related thereto
10/21/1999WO1999032428A8 Synthesis of diamines
10/21/1999DE19816932A1 New dipeptide derivatives useful as neuropeptide Y agonists and/or antagonists for treating cardiovascular disorders, coronary, cerebral or renal vasospasms, obesity, bulimia and asthma
10/21/1999DE19816922A1 Synthetic cyclic peptides used as models for conformational analysis and as potential drugs
10/21/1999DE19816915A1 New dipeptide derivatives useful as neuropeptide Y agonists and/or antagonists for treating cardiovascular disorders, coronary, cerebral or renal vasospasms, obesity, bulimia and asthma
10/21/1999DE19816903A1 New dipeptide derivatives useful as neuropeptide Y agonists and/or antagonists for treating cardiovascular disorders, coronary, cerebral or renal vasospasms, obesity, bulimia and asthma
10/21/1999CA2326665A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999CA2325629A1 Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide
10/21/1999CA2325572A1 Process for the preparation of resin-bound cyclic peptides
10/21/1999CA2324988A1 Methods for treatment and prevention of infections
10/21/1999CA2323934A1 Nucleic acid sequences and proteins associated with aging
10/20/1999EP0950664A1 Process for producing n-glycyltyrosine
10/20/1999EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999EP0783318A4 Inhibitors of farnesyl-protein transferase
10/19/1999US5969132 Macrocyclic difluorostatone derivatives useful as antiviral agents
10/19/1999US5969126 GNRH-leukotoxin chimeras
10/19/1999US5969100 Peptide, peptide analog and amino acid analog protease inhibitors
10/19/1999US5968970 Treatment of hiv
10/19/1999US5968942 Inhibitors of hiv protease
10/19/1999US5968927 Azepino-indole compounds; treatment of inflammatory, autoimmune and neurodegenerative diseases, prevention of ischemic injury
10/19/1999US5968924 Benzo-fused lactams promote release of growth hormone
10/19/1999US5968753 Peptides which displace a monoclonal antibody bound to a cell surface antigen on a target cell; for separating specific cells like cd34 positive hematopoeitic stem cells from a heterogeneous cell population